Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (27 ops.)
Latest filing published 24 Aug 2026 for U S Physical Therapy INC /nv, €51k.
Filing timeline
BuySaleGraham D. Reeve
Insider track record
Disclosed buys
0
Disclosed sells
27
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Graham D. Reeve: trading record in brief
Graham D. Reeve is a declared insider of U S Physical Therapy INC /nv (senior executive), with filings sourced from SEC (Form 4). The record holds 37 filings, for trades running from 5 March 2018 to 20 August 2026.
No open-market purchase appears, only 27 sales worth €3.6M. Outside the open market, there are 10 share grants. In 2026 alone, the filings show no purchases and 3 sales.
The latest filing, published on 24 August 2026, reports a share grant of €51k in U S Physical Therapy INC /nv. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Graham D. Reeve
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations26 total
762 shares@ US$78.00Common StockSEC:0001193125-26-363888:0
662 shares@ US$78.861.5% of flowCommon StockSEC:0001193125-26-104315:0
1,807 shares@ US$82.254.1% of flowCommon StockSEC:0001193125-26-102296:0
10,000 shares0Common StockSEC:0001193125-26-072703:0
743 shares@ US$71.011.6% of flowCommon StockSEC:0001193125-25-297192:0
763 shares@ US$84.971.9% of flowCommon StockSEC:0000950170-25-110761:0
1,792 shares@ US$86.574.7% of flowCommon StockSEC:0000950170-25-107551:0
530 shares@ US$78.081.2% of flowCommon StockSEC:0000950170-25-076382:0
1,730 shares@ US$82.114.3% of flowCommon StockSEC:0000950170-25-035831:0
8,100 shares0Common StockSEC:0000950170-25-028166:0
1,724 shares@ US$96.295.0% of flowCommon StockSEC:0000950170-24-125739:0
1,724 shares@ US$82.504.1% of flowCommon StockSEC:0000950170-24-099579:0
1,724 shares@ US$105.465.5% of flowCommon StockSEC:0000950170-24-059850:0
2,629 shares@ US$104.398.2% of flowCommon StockSEC:0000950170-24-026491:0
8,100 shares0Common StockSEC:0000950170-24-022520:0
1,500 shares@ US$87.393.9% of flowCommon StockSEC:0001209191-23-055567:0
4,114 shares@ US$109.9913.3% of flowCommon StockSEC:0001209191-23-045664:0
1,912 shares@ US$100.955.9% of flowCommon StockSEC:0001209191-23-016252:0
5,000 shares0Common StockSEC:0001209191-23-012208:0
1,909 shares@ US$84.795.3% of flowCommon StockSEC:0001209191-22-056112:0
3,818 shares@ US$92.2411.2% of flowCommon StockSEC:0001209191-22-045144:0
10,000 shares0Common StockSEC:0001209191-22-018694:0
2,118 shares@ US$90.755.6% of flowCommon StockCommon StockSEC:0001209191-22-014493:0
1,000 shares@ US$94.192.7% of flowCommon StockSEC:0001209191-21-068262:0
1,559 shares@ US$114.154.9% of flowCommon StockSEC:0001209191-21-050678:0
25 of 26 declarations
